Showing results (321-330 of 662) with videos related to

Sort By:
Pageof 67
Plos Pathogens|August 31, 2022
HIV infected CD4+ T cell clones are more stable than uninfected clones during long-term antiretroviral therapyShuang Guo, Brian T Luke, Amy R Henry, et al.
The Journal of Infectious Diseases|January 22, 2011
Plasma levels of soluble CD14 independently predict mortality in HIV infectionNetanya G Sandler, Handan Wand, Annelys Roque, et al.
The New England Journal of Medicine|August 9, 2002
Antiretroviral-drug resistance among patients recently infected with HIVSusan J Little, Sarah Holte, Jean-Pierre Routy, et al.
Plos One|November 16, 2016
Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)Michelle C Crank, Eleanor M P Wilson, Laura Novik, et al.
Clinical Pharmacology and Therapeutics|September 1, 2020
Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics ApproachJerry Li, Mina Nikanjam, Coleen K Cunningham, et al.
Nature Medicine|August 23, 2011
CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primatesNancy J Sullivan, Lisa Hensley, Clement Asiedu, et al.
Plos Pathogens|May 27, 2010
Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus SpeciesLisa E Hensley, Sabue Mulangu, Clement Asiedu, et al.
The Journal of Infectious Diseases|July 13, 2013
Effect of antiretroviral therapy on HIV reservoirs in elite controllersTae-Wook Chun, J Shawn Justement, Danielle Murray, et al.
Pageof 67